These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20074901)

  • 1. Therapeutic targets for persistent airway inflammation in refractory asthma.
    Murphy P; Hillman T; Rajakulasingam K
    Biomed Pharmacother; 2010 Feb; 64(2):140-5. PubMed ID: 20074901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation as asthma therapy: where do we stand?
    Barnes PJ
    Eur Respir J Suppl; 1996 Aug; 22():154s-159s. PubMed ID: 8871062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists.
    Currie GP; Srivastava P; Dempsey OJ; Lee DK
    QJM; 2005 Mar; 98(3):171-82. PubMed ID: 15728398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New trends in asthma therapy: is there a place for biologicals in 2007?].
    Bart PA
    Rev Med Suisse; 2007 Jan; 3(94):103-6. PubMed ID: 17354533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and emerging therapies for asthma.
    Leath TM; Singla M; Peters SP
    Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe asthma: new therapeutic targets].
    Aubier M
    Bull Acad Natl Med; 2010 Jun; 194(6):1009-19. PubMed ID: 21513135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileukotriene agents in asthma: the dart that kills the elephant?
    Renzi PM
    CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin E blockade in the treatment of asthma.
    Kuhn R
    Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.
    Mogil J
    J Am Acad Nurse Pract; 2007 Sep; 19(9):459-70. PubMed ID: 17760570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin E-mediated airway inflammation is active in most patients with asthma.
    Hayden ML
    J Am Acad Nurse Pract; 2007 Sep; 19(9):439-49. PubMed ID: 17760568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients.
    Tug T; Godekmerdan A; Sari N; Karatas F; Erdem ES
    Clin Pharmacol Ther; 2007 Mar; 81(3):371-6. PubMed ID: 17339866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends and directions in the rationalization of pharmacotherapy of bronchial asthma: probing for alternatives.
    Das BP; Sethi A
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):368-78. PubMed ID: 18603937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Future perspectives in the therapy of asthma in children].
    Tosca MA; Villa E; Rossi GA
    Minerva Pediatr; 2008 Apr; 60(2):235-47. PubMed ID: 18449140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene antagonists. Do they offer new hope for asthmatics?
    Thien F
    Aust Fam Physician; 2000 Jun; 29(6):547-51. PubMed ID: 10863810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The future of asthma therapy].
    Solèr M
    Schweiz Med Wochenschr; 2000 Feb; 130(8):277-81. PubMed ID: 10726286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-leukotrienes: a new class of drugs to integrate into the therapeutic strategy of asthma].
    Fellrath JM; Leuenberger P; Weilenmann C; Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):217-26. PubMed ID: 10218418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating asthma: is there a place for leukotriene receptor antagonists?
    Diamant Z; van der Molen T
    Respir Med; 2005 Jun; 99(6):655-62. PubMed ID: 15878481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood asthma: treatment update.
    Courtney AU; McCarter DF; Pollart SM
    Am Fam Physician; 2005 May; 71(10):1959-68. PubMed ID: 15926412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.